HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 292/6/E1782    most recent 00639.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Holloway, G. P. Articles by Spriet, L. L. Search for Related Content PubMed PubMed Citation Articles by Holloway, G. P. Articles by Spriet, L. L.

Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women

¹Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario; ²Department of Medicine, McMaster University, Hamilton, Ontario, Canada; and ³Thrombosis Research Laboratory, Otsuka Maryland Medicinal Laboratories, Rockville, Maryland

Submitted 22 November 2006 ; accepted in final form 4 February 2007

A reduction in fatty acid oxidation has been associated with lipid accumulation and insulin resistance in the skeletal muscle of obese individuals. We examined whether this decrease in fatty acid oxidation was attributable to a reduction in muscle mitochondrial content and/or a dysfunction in fatty acid oxidation within mitochondria obtained from skeletal muscle of age-matched, lean [body mass index (BMI) = 23.3 ± 0.7 kg/m²] and obese women (BMI = 37.6 ± 2.2 kg/m²). The mitochondrial marker enzymes citrate synthase (–34%), -hydroxyacyl-CoA dehydrogenase (–17%), and cytochrome c oxidase (–32%) were reduced (P < 0.05) in obese participants, indicating that mitochondrial content was diminished. Obesity did not alter the ability of isolated mitochondria to oxidize palmitate; however, fatty acid oxidation was reduced at the whole muscle level by 28% (P < 0.05) in the obese. Mitochondrial fatty acid translocase (FAT/CD36) did not differ in lean and obese individuals, but mitochondrial FAT/CD36 was correlated with mitochondrial fatty acid oxidation (r = 0.67, P < 0.05). We conclude that the reduction in fatty acid oxidation in obese individuals is attributable to a decrease in mitochondrial content, not to an intrinsic defect in the mitochondria obtained from skeletal muscle of obese individuals. In addition, it appears that mitochondrial FAT/CD36 may be involved in regulating fatty acid oxidation in human skeletal muscle.

obesity; mitochondria; fatty acid translocase/CD36; transport proteins

This article has been cited by other articles:

				G. P. Holloway, C. R. Benton, K. L. Mullen, Y. Yoshida, L. A. Snook, X.-X. Han, J. F. C. Glatz, J. J. F. P. Luiken, J. Lally, D. J. Dyck, et al. In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E738 - E747. [Abstract] [Full Text] [PDF]

				K. L. Mullen, J. Pritchard, I. Ritchie, L. A. Snook, A. Chabowski, A. Bonen, D. Wright, and D. J. Dyck Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2009; 296(2): R243 - R251. [Abstract] [Full Text] [PDF]

				K. R Short Introduction to symposium proceedings: the emerging interplay among muscle mitochondrial function, nutrition, and disease Am. J. Clinical Nutrition, January 1, 2009; 89(1): 453S - 454S. [Full Text] [PDF]

				G. P Holloway, A. Bonen, and L. L Spriet Regulation of skeletal muscle mitochondrial fatty acid metabolism in lean and obese individuals Am. J. Clinical Nutrition, January 1, 2009; 89(1): 455S - 462S. [Abstract] [Full Text] [PDF]

				J. O Holloszy Skeletal muscle "mitochondrial deficiency" does not mediate insulin resistance Am. J. Clinical Nutrition, January 1, 2009; 89(1): 463S - 466S. [Abstract] [Full Text] [PDF]

				L. P Turcotte and J. S Fisher Skeletal Muscle Insulin Resistance: Roles of Fatty Acid Metabolism and Exercise Physical Therapy, November 1, 2008; 88(11): 1279 - 1296. [Abstract] [Full Text] [PDF]

				G. P. Holloway, C. G. R. Perry, A. B. Thrush, G. J. F. Heigenhauser, D. J. Dyck, A. Bonen, and L. L. Spriet PGC-1{alpha}'s relationship with skeletal muscle palmitate oxidation is not present with obesity despite maintained PGC-1{alpha} and PGC-1{beta} protein Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E1060 - E1069. [Abstract] [Full Text] [PDF]

				C. R. Benton, G. P. Holloway, S. E. Campbell, Y. Yoshida, N. N. Tandon, J. F. C. Glatz, J. J. J. F. P. Luiken, L. L. Spriet, and A. Bonen Rosiglitazone increases fatty acid oxidation and fatty acid translocase (FAT/CD36) but not carnitine palmitoyltransferase I in rat muscle mitochondria J. Physiol., March 15, 2008; 586(6): 1755 - 1766. [Abstract] [Full Text] [PDF]

				Arend. Bonen, Hideo. Hatta, G. P. Holloway, L. L. Spriet, and Y. Yoshida Reply from Arend Bonen, Hideo Hatta, Graham P. Holloway, Lawrence L. Spriet and Yuko Yoshida J. Physiol., October 15, 2007; 584(2): 707 - 708. [Full Text] [PDF]

				X.-X. Han, A. Chabowski, N. N. Tandon, J. Calles-Escandon, J. F. C. Glatz, J. J. F. P. Luiken, and A. Bonen Metabolic challenges reveal impaired fatty acid metabolism and translocation of FAT/CD36 but not FABPpm in obese Zucker rat muscle Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E566 - E575. [Abstract] [Full Text] [PDF]